Menopause Essentials Update 2025

This Menopause Essentials Update was designed as a wrap up of evidence-based management options for menopause and midlife health.

Starting with structuring the initial consultation in the most effective way and finishing with a discussion of complex cases, the Menopause Essentials Update included the latest on hormonal and non-hormonal options and up to date best-practice risk management recommendations across the full spectrum of menopause medicine. 

Speakers include: Dr Amie Hanlon, Dr Christina Jang, Dr Samantha Kerr, and Dr Hannah Farquhar. 

Interview with Dr Hannah Farquhar about her presentation

Q: Regarding Menopausal Hormone therapy, what information are you sharing with your medical colleagues? 

A: How we can safely prescribe menopausal hormone therapy (MHT), including the different hormonal preparations, indications and contraindications, and the benefits and risks.

Q: What key takeaways are you hoping people take from the MEU?

A: Firstly, how to individualise care for women experiencing menopause, and understanding that it's not a 'one size fits all' approach. Secondly, how to discuss the various management options with women to enable shared decision making. 

Q: Is there anything specific you’d like to add?

A: It's exciting that there is an increasing interest in menopausal health, and that we have an opportunity to provide education to further enhance awareness and understanding of the evidence. 

Program 

The menopause consultation: Dr Samantha Kerr

Prescribing menopausal hormone therapy: Dr Hannah Farquhar

Non-hormonal therapies: Dr Christina Jang

Management of bleeding on and off MHT: Dr Amie Hanlon

Panel discussion (all speakers): Cases | Q+A

CPD

RACGP approval as 3.5 hours of EA (Activity number 1220811)

ACRRM  approval for 2.5hrs EA and 1hr RP (Activity number 36507)

RANZCOG approval (Activity number 1,203) Educational Activities: 3.50 (Conference / workshop / course attendance).

Learning Outcomes

1. Describe how to diagnose and manage menopause within a structured consultation in primary healthcare setting. 

2. Identify the benefits and risks of menopausal hormone therapy. 

3. Describe the different non- hormonal treatment options for the symptoms of menopause. 

4. Describe how to tailor treatment for complex cases to ensure patient safety 

5. Identify the “red flags” for investigation of peri and postmenopausal bleeding

How to view

The MEU recording is free for AMS Members, non-members are charged

Go to https://elearning.menopause.org.au/

Content updated 3 July 2025